De Bari, B.; Lefevre, L.; Henriques, J.; Gatta, R.; Falcoz, A.; Mathieu, P.; Borg, C.; Dinapoli, N.; Boulahdour, H.; Boldrini, L.;
et al. Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer? Cancers 2022, 14, 4043.
https://doi.org/10.3390/cancers14164043
AMA Style
De Bari B, Lefevre L, Henriques J, Gatta R, Falcoz A, Mathieu P, Borg C, Dinapoli N, Boulahdour H, Boldrini L,
et al. Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer? Cancers. 2022; 14(16):4043.
https://doi.org/10.3390/cancers14164043
Chicago/Turabian Style
De Bari, Berardino, Loriane Lefevre, Julie Henriques, Roberto Gatta, Antoine Falcoz, Pierre Mathieu, Christophe Borg, Nicola Dinapoli, Hatem Boulahdour, Luca Boldrini,
and et al. 2022. "Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?" Cancers 14, no. 16: 4043.
https://doi.org/10.3390/cancers14164043
APA Style
De Bari, B., Lefevre, L., Henriques, J., Gatta, R., Falcoz, A., Mathieu, P., Borg, C., Dinapoli, N., Boulahdour, H., Boldrini, L., Valentini, V., & Vernerey, D.
(2022). Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer? Cancers, 14(16), 4043.
https://doi.org/10.3390/cancers14164043